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Perkinsus marinus is a protozoan parasite of the eastern
oyster Crassostrea virginica. Mortalities caused by this parasite
typically occur in the second summer of infection and have
been responsible for much of the recent decline in the oyster
fishery along the eastern seaboard of the United States (3, 15).
The molecular mechanisms of parasite infectivity, virulence,
and interaction with the host defense system are largely unknown. The development of media formulations allowing axenic culture of P. marinus has provided new opportunities to
assess the effects of host components on parasite growth, physiology, and infectivity. There are several media formulations
for in vitro P. marinus culture that employ commercial base
formulations (e.g., Dulbecco modified Eagle’s medium with
Ham’s F-12 nutrient mixture) supplemented with such constituents as cod liver oil, bovine serum albumin, yeastolate, or
fetal bovine serum (FBS) or its ␣-fetoprotein constituent, fetuin (11, 18, 19, 21, 23, 26). There is also a chemically defined,
protein-free medium (ODRP-3 [25]) which has proven to be of
particular value for the production of antibodies against P.
marinus extracellular products (12).
The in vivo P. marinus life cycle begins with a small, immature trophozoite that enlarges over time into a “signet ring”
form, so named for its large vacuole and offset nucleus. This
mature trophozoite may then undergo palintomic fission, in
which 4 to 64 or more immature trophozoites are formed
within, then exit from, the parental cell, or tomont, wall (35). P.
marinus can also form motile zoospores, again by palintomic
fission, with exit of the zoospores through a discharge tube and
pore structure formed on the wall of the enlarged parental
trophozoite, the zoosporangium (35). During in vitro culture in

ODRP-3 medium, cellular proliferation is apparently solely by
binary fission, and no zoosporulation is seen. In an effort to
more closely simulate, in vitro, the milieu to which P. marinus
is exposed in vivo, oyster tissue homogenate and plasma from
P. marinus-susceptible and -tolerant oyster species have been
employed as culture supplements (20, 21, 29). Compared with
growth in unsupplemented ODRP-3, P. marinus cells grown in
the presence of plasma supplements from Crassostrea gigas,
Crassostrea ariakensis, or infected C. virginica oysters show
reduced in vitro proliferation (20). Uninfected C. virginica
plasma supplementation, however, results in only minimal inhibition of proliferation (20, 29). Oyster tissue homogenatesupplemented medium produces marked changes in cell
proliferation, morphology, and differentiation, including enlargement of trophozoites and induction of tomont stages,
which are rarely seen in unsupplemented ODRP-3 medium but
are commonly observed during infection (29).
Several studies have implicated proteases as contributing
factors in P. marinus virulence (17, 28, 32, 33). The extracellular products of P. marinus cells grown in ODRP-3 contain
only high-molecular-mass (⬎50-kDa) proteases (29). However, when C. virginica plasma or homogenate is used as a
media supplement, there is significant alteration in P. marinus
protease expression patterns, including a simultaneous downregulation of high-molecular-mass proteases and upregulation
of low-molecular-mass (⬍50-kDa) proteases. These changes
are not seen when cells are exposed to homogenates from C.
gigas and C. ariakensis oysters (29), both of which have been
reported to be more tolerant of P. marinus infection than is C.
virginica (2, 7, 8, 30).
It is not clear if there is an association between the observed
changes in cellular morphology and the shifts in the secreted
protease profiles in supplemented cultures, or whether either is
associated with parasite infectivity. In order to better under-
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The protozoan oyster parasite Perkinsus marinus can be cultured in vitro in a variety of media; however, this
has been associated with a rapid attenuation of infectivity. Supplementation of defined media with products of
P. marinus-susceptible (Crassostrea virginica) and -tolerant (Crassostrea gigas, Crassostrea ariakensis) oysters
alters proliferation and protease expression profiles and induces differentiation into morphological forms
typically seen in vivo. It was not known if attenuation could be reversed by host extract supplementation. To
investigate correlations among these changes as well as their association with infectivity, the effects of medium
supplementation with tissue homogenates from both susceptible and tolerant oyster species were examined.
The supplements markedly altered both cell size and proliferation, regardless of species; however, upregulation
of low-molecular-weight protease expression was most prominent with susceptible oysters extracts. Increased
infectivity occurred with the use of oyster product-supplemented media, but it was not consistently associated
with changes in cell size, cell morphology, or protease secretion and was not related to the susceptibility of the
oyster species used as the supplement source.
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stand these relationships, protease production, in vitro cell size
and morphology, and infectivity were assessed under various
conditions. Observations were made of variations in these factors among clonal P. marinus isolates, and then one isolate was
selected for investigation of alterations in the presence of various host-derived media supplements. A detailed observation
of the effects of tissue-based supplements derived from susceptible and tolerant oysters was then performed, and a selected dosage level was used to investigate infectivity using a
variety of oyster populations and species.
MATERIALS AND METHODS

destained in the same solution, without the stain. The gels were then assessed for
the presence of cleared bands corresponding to the location of gelatinolytic
proteases. Since the gels were, by necessity, run under nonreducing conditions,
no attempt was made to assign absolute molecular masses to them. The proteases
are, for convenience, referred to as high- (⬎50-kDa) and low- (⬍ 50-kDa)
molecular mass species.
Assessment of differences in infectivity among several isolates of P. marinus.
P. marinus clonal isolates LA10-1 (ATCC 50906; genotype 4), MA2-11 (ATCC
50896; genotype 1), SC3-2 (genotype 3) (6), and P-1 (genotype 9) (13), and the
isolate HVA-18 (ATCC 50764; genotype 8) (6) were cultured for use in an
infection trial and were selected based on previous genotype identification at
eight polymorphic loci (38). The HVA-18 isolate was not initially cloned; however, genetic analysis of this isolate at three loci showed little genetic variability,
supporting the possibility that it has become clonal by serial passage (unpublished data). All cultures were seeded at 106 cells per ml in 75-cm2 flasks
containing 50 ml of a supplemented Dulbecco modified Eagle’s medium-Ham’s
medium with 5% FBS, commonly known as Dungan’s medium (11, 16). Cultures
were maintained in a humidified incubator at 27°C under 5% CO2 for 3 weeks
and harvested for oyster challenge, and the culture supernatants were assayed by
zymography. Prior to challenge, cells were enumerated by hemacytometer and
their mean was size estimated using an ocular micrometer. Twenty C. virginica
ME oysters per group were subjected to experimental infection.
Assessment of the effects of oyster plasma and tissue homogenate supplementation on P. marinus infectivity. The P-1 isolate of P. marinus was chosen for
further study based on its demonstrated potential to alter its secretion profile of
high- and low-molecular-mass proteases following media supplementation. Both
plasma and tissue homogenate-supplemented media induced similar changes in
P-1 protease expression, but only homogenate altered cell size and morphology,
allowing the opportunity to distinguish correlations between these alterations
and parasite infectivity. Hemolymph was withdrawn from the adductor muscle
through a shell notch in three C. virginica ME oysters, using a syringe fitted with
a 25-gauge needle. The hemocytes were removed by centrifugation (500 ⫻ g, 5
min), and the plasma was pooled and filtered through a 0.22-m filter (Star LB;
Costar, Corning, Inc., Acton, Mass.). The oyster tissues were pooled and processed for homogenate basically in the manner described in MacIntyre et al. (29).
Briefly, the oyster soft tissue was finely minced, suspended in 10 ml of cold
artificial seawater, and homogenized using a glass Tenbroek homogenizer. This
homogenate was centrifuged for 30 min at 2,500 ⫻ g at 4°C, and the supernatant
was withdrawn and centrifuged at 12,000 ⫻ g for an additional 30 min at 4°C.
This partially clarified homogenate was then filtered to 0.22 m by syringe filters,
and the protein content was assayed by the bicinchoninic acid technique (Pierce,
Rockford, Ill.).
Cultures of the P-1 isolate of P. marinus were seeded at 106 cells per ml in
75-cm2 flasks containing 50 ml of ODRP-3 medium without supplementation or
supplemented with 0.3 mg of plasma/ml or 0.3 mg of tissue homogenate/ml. The
P. marinus cells used in this experiment had been cultured on a long-term basis
in unsupplemented ODRP-3 prior to exposure to the media supplements. Cultures were maintained in a humidified incubator at 27°C under 5% CO2 for 4
weeks. Cells were then harvested for oyster challenge, and the culture supernatants were assayed by zymography. Prior to challenge, cells were enumerated by
hemacytometer and their mean size was estimated using an ocular micrometer.
Thirty C. virginica ME oysters per group were subjected to experimental infection.
Assessment of the effects of homogenate supplementation on P. marinus cell
size, morphology, and life stages. In view of the restitution of infectivity and
superior induction of proteases by oyster homogenate (see Results), it was
elected to investigate in greater detail the effects of homogenate supplementation on the P. marinus P-1 isolate. Cells were cultured in ODRP-3 medium
supplemented with homogenates of tissues from five individual C. virginica WA,
C. gigas, and C. ariakensis oysters. FBS and fetuin were used as control supplements. ODRP-3 medium was supplemented at 1.0, 0.33, 0.11, 0.037, 0.012, and
0.004 mg/ml on a protein basis or was left unsupplemented. Each well was seeded
with 106 P. marinus cells in 1 ml of medium in duplicated 48-well tissue culture
plates. An additional set of unseeded plates were maintained as media controls.
All plates were held in a humidified incubator at 27°C under 5% CO2 for 6
weeks.
Following incubation, the cells were resuspended (30 100-l passages through
a 200-l pipette tip) prior to hemacytometer counts of single and clustered
trophozoites. The exact enumeration of the cells within clusters was not possible,
as they were extremely adherent, and thus clusters were ranked as groups of 2 to
3, 4, 5 to 16, and greater than 16 cells. Additionally, measurements of cell
diameters of 10 trophozoites were completed for each culture well using an
ocular micrometer, at a magnification of ⫻400. In order to simultaneously
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Animals. Experimental oysters were maintained in 1-m-filtered York River
(Va.) water and fed commercially produced algae (Reed Mariculture, San Jose,
Calif.). Water changes were performed twice weekly, and all effluent water was
chlorinated prior to release. P. marinus-free C. virginica oysters from Maine (C.
virginica ME; Pemaquid Oyster Company, Waldoboro, Maine) were initially
employed, but the occurrence of P. marinus infections in those oysters over the
course of this study necessitated the importation of disease-free C. virginica
oysters from Washington state (C. virginica WA; Taylor Shellfish Farms, Shelton,
Wash.). C. gigas oysters were purchased from Taylor Shellfish Farms. C. virginica
oysters originally from populations in Louisiana (C. virginica LA), Tangier Sound
(C. virginica TG) in the Chesapeake Bay (Va.), and the CROSBreed program (C.
virginica XB; selectively bred for P. marinus resistance) were all gathered from a
single deployment site in the Yeocomico River, a tributary of the Potomac River
(Va.) near its entrance to the Chesapeake Bay. C. ariakensis oysters were provided by the Virginia Institute of Marine Science oyster hatchery. A subsample
of both the C. virginica ME and C. virginica WA oysters used in infection trials
was confirmed to be P. marinus-free by body burden analysis (see below).
Infection trials and analysis of P. marinus body burden. Oysters were infected
by injection of parasites into the mantle cavity through a small hole in the shell
made with a lapidary saw. Each oyster was injected with 106 parasite cells
suspended in 100 l of artificial seawater (20 ppt; Forty Fathoms Marine Mix;
Marine Enterprises International, Baltimore, Md.) on days 1, 3, and 5, and a
sham group was injected with artificial seawater. The oysters were maintained at
a density of 10 to 15 per 35-liter aquarium and sacrificed after 4 weeks for
analysis of P. marinus infection level.
In order to most accurately and sensitively quantify the infection level following experimental infection, P. marinus cells were enumerated using the whole
body burden technique (10, 14). Briefly, the oyster soft tissues were finely minced
and incubated at room temperature for 7 days in 20 ml of fluid thioglycolate
medium (2.9% FTM; T-9032; Sigma-Aldrich, Inc., St. Louis, Mo.; 2% NaCl)
supplemented with penicillin-streptomycin solution (5% [vol/vol]; P-0781; Sigma-Aldrich, Inc.). Following incubation, the tissue was pelleted by centrifugation, resuspended in 20 ml of 2 M NaOH, and held at 60°C for 3 to 4 h to dissolve
the oyster tissue. The enlarged P. marinus prezoosporangia (hypnospores) were
then pelleted, washed three times in distilled water, stained with a 1:5 dilution of
Lugol’s iodine, immobilized on a 0.45-m filter by vacuum, and enumerated by
light microscopy. When necessary, dilutions of the hypnospores were made in
distilled water and counted in triplicate, and the mean count was extrapolated to
the volume of the sample. The resultant counts were loge transformed for
analysis of variance and for Tukey’s multiple comparisons test, using a 5% error
rate.
Analysis of proteolytic enzyme expression. Supernatants from P. marinus cultures and their respective media controls were analyzed for protease production
by zymography. Twenty microliters of media or culture supernatant was electrophoresed under nonreducing conditions by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (24) using an 8% polyacrylamide separating gel copolymerized with 0.1% porcine gelatin (G-8150; Sigma-Aldrich, Inc.)
and a 4% stacking gel. Following electrophoresis, the gels were washed three
times for 10 min in 2.5% Triton X-100 (BP151; Fisher Scientific, Fairlawn, N.J.)
to renature the proteins and then once in 0.1 M Tris HCl (pH 8.0; BP152; Fisher
Scientific). The gels were then incubated at 37°C in a fresh change of Tris HCl
(pH 8.0) buffer. While use of buffers from pH 4.0 to 9.0 have previously been
shown not to alter the P. marinus zymographic profile, pH 8.0 is optimum for
detection of P. marinus proteolytic activities by zymogram (27) and has been
specifically used for the study of the modulation of protease expression under
various media supplementation schemes (29). Following incubation, the gels
were stained overnight in Coomassie brilliant blue G-250 (0.1%; 161-0406; BioRad, Hercules, Calif.) in 40% methanol–10% acetic acid. The gels were
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RESULTS
P. marinus clonal isolates display a range of infectivity and
protease expression. P. marinus clonal isolate cell diameters
were consistent within each group, ranging from 2 m (SC3-2)
to 4 m (LA10-1, MA2-11, and P-1). The cell size of the
HVA-18 isolate was more variable, ranging from 2 to 6 m. All
cells in the cultures were single trophozoites, with little to no
clustering of cells. There were significant differences in the
oyster P. marinus body burdens 4 weeks after experimental
infection (Fig. 1A), with body burdens in all groups significantly greater than that in SC3-2. The LA10-1, P-1, and
HVA-18 isolates were not significantly different. The MA2-11
isolate was significantly more infective than both the P-1 and
the HVA-18 isolates. There were no mortalities, and all shaminjected oysters were negative for P. marinus infection.
Low-molecular-weight proteases were most strongly expressed
in the culture supernatants of HVA-18 and MA2-11 (Fig. 1B).
The LA10-1 and P-1 isolates also showed some weak low-molecular-weight protease activity. High-molecular-weight proteases
were most prominent in the HVA-18 and P-1 culture supernatants. The SC3-2 culture supernatant did not have any apparent
protease activity. The FBS proteins, which can be visualized as
dark bands on the zymogram, were degraded to some extent in
the MA2-11 and P-1 cultures and were completely degraded in
the HVA-18 culture.
Infectivity of P. marinus isolate P-1 is increased by medium
supplementation with oyster plasma or tissue homogenate.
Unsupplemented cells and cells supplemented with plasma
were similarly sized, with most cells being 5 to 6 m. The
homogenate-supplemented cells were larger, at ⬃10 m, and
had frequent multicellular tomont structures, as well as numerous clusters of adherent cells. These were not seen in the
plasma-supplemented or the unsupplemented cultures. Gelatin zymograms demonstrated production of low-molecularweight proteases in supplemented cultures, with greater activity induced by homogenate supplementation (Fig. 2B). The
media controls did not demonstrate any proteolytic activity.
Infection levels at 4 weeks were significantly higher in oysters challenged with P. marinus from supplemented cultures

FIG. 1. Infectivity level and secreted protease profiles of selected P.
marinus isolates. (A) Mean body burden ⫾ standard error of oysters
infected with P. marinus isolates. Cells were grown for 3 weeks in
Dungan’s medium at 27°C in 5% CO2 and then injected at 106 cells per
oyster per day on days 1, 3, and 5 into 20 C. virginica ME oysters per
group. After 4 weeks, the oysters were sacrificed and total P. marinus
body burden was assessed and loge transformed for statistical analysis.
Groups with different numbers were significantly different (P ⬍ 0.001).
(B) Gelatin zymogram of 20 l of culture supernatant from P. marinus
isolate cultures used in the above infection trial. Nonreducing, 8%
acrylamide, 0.1% porcine gelatin SDS-PAGE gels were incubated for
3 h at 37°C in 0.1 M Tris HCl, pH 8.0, and then stained with Coomassie
brilliant blue G-250. Molecular masses are in kilodaltons.

than in those grown in ODRP-3 medium (Fig. 2A). Shaminjected controls were all negative for P. marinus infection.
There were 7, 9, 10, and 3 oyster mortalities in the homogenate, plasma, unsupplemented, and sham injection groups
through the course of the experiment. The cause of the mortalities could not be determined due to rapid degradation of
the oyster tissues.
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compare changes in both cell volume and count, a pellet volume was calculated
as the average cell volume [(4/3)r3] multiplied by the estimated total cell
number, with cell numbers in clusters estimated by multiplying by 2.5, 4, 10.5, and
32 times the number of clusters of 2 to 3, 4, 5 to 16, and ⬎16 cells, respectively.
The volume of the ODRP-3 controls was then subtracted from all groups to
assess deviation from the control culture. Culture supernatants from all treatments were analyzed for protease activity by zymography.
Assessment of the effects of homogenate supplementation from different Crassostrea species and C. virginica populations on P. marinus infectivity. Oyster
tissue homogenates were produced from pooled tissues of three oysters from
each of the test groups, C. virginica LA, C. virginica TG, C. virginica XB, C.
virginica WA, C. gigas, and C. ariakensis. Cultures of the P-1 isolate of P. marinus
were seeded at 106 cells per ml in 75-cm2 flasks containing 50 ml of ODRP-3
medium without supplementation or supplemented at 0.25 mg/ml with homogenates from each of the oyster groups. This supplementation level was chosen
based on prior observations of alterations in P. marinus culture cell count,
morphological characteristics, and protease production. Cultures were maintained in a humidified incubator at 27°C under 5% CO2 for 4 weeks. Cells were
then harvested for oyster challenge, and the culture supernatants were retained
for zymography. Prior to challenge, cells were enumerated by hemacytometer
and their mean size was estimated by measurement of 10 cells per treatment
using an ocular micrometer. Thirty C. virginica WA oysters per group were
subjected to experimental infection.
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Oyster tissue homogenate alters P. marinus proliferation,
size, morphology, and protease expression. Oyster homogenate supplements from all three oyster species resulted in the
occurrence of multicellular clusters, which were resistant to
disaggregation by pipetting (Fig. 3 and 4). While no shared
exterior wall could be visualized, these multicellular clusters
were often compressed and were similar in appearance to
tomonts. P-1 isolate total cell counts were diminished by oyster
homogenate supplementation, regardless of the oyster species
(Fig. 3). This effect was dose dependent, with some effect seen
even at the lowest supplementation levels. Cells supplemented
with C. ariakensis homogenate at 1.0 mg/ml appeared to be
nonviable, as assessed by neutral red uptake. Supplementation
with fetuin was associated with minor diminishment in the
number of cells at low and intermediate concentrations and a
moderate increase in cell count at the 1.0-mg/ml supplementation level (Fig. 3). Cultures supplemented with FBS behaved
similarly to those supplemented with fetuin; however, there
was a large increase in proliferation at the highest supplementation levels. When supplemented at 1.0 mg/ml with FBS, the
P. marinus cell count was approximately 2.5-fold higher than in
the ODRP-3 control.
Most multicellular clusters observed in the homogenatesupplemented medium consisted of 5 to 16 aggregated cells.
The degree of cell clustering was dose dependent and was
typically maximal at intermediate supplement concentrations.
The C. virginica WA-supplemented cultures had a peak in the
number of clusters at 0.11 mg/ml and maintained clusters to
the highest dose tested. C. ariakensis- and C. gigas-supplemented cultures had a peak in cell clustering at the lower
supplementation level of 0.037 mg/ml. There was a precipitous
decline in the occurrence of these clusters at the 0.33-mg/ml
dose for C. ariakensis and at the 1.0-mg/ml dose for C. gigas.
Neither fetuin nor FBS supplementation was associated with
formation of multicellular clusters.
Homogenate supplementation from all three oyster species
also resulted in a dose-dependent increase in the mean P.
marinus cell size (Fig. 4 and 5). Cells supplemented at 1.0
mg/ml had an over-threefold-larger diameter than unsupplemented cells. Neither FBS nor fetuin supplementation resulted
in a change in the cell size compared with the ODRP-3 control.
The calculated cell pellet volume was greater than that of
unsupplemented cultures at the highest supplementation levels
for FBS-, fetuin-, and C. virginica WA-supplemented cultures
(Fig. 5B). Both C. ariakensis- and C. gigas-supplemented cultures had volumes greater than unsupplemented cultures only
at the 0.33-mg/ml supplementation level.
A dose-dependent increase in low-molecular-weight protease production was observed, as expected, in cultures supplemented with C. virginica WA oyster homogenate (Fig. 6).
Homogenates from the P. marinus-tolerant C. gigas oysters did
not induce low-molecular-weight proteases. The C. ariakensis
oyster homogenate induced low-molecular-weight proteases
only at the 1.0-mg/ml supplementation level, and these bands
were faint and difficult to visualize on the zymogram. Both FBS
and fetuin induced low-molecular-weight proteases at supplementation levels of 0.33 mg/ml and above. Oyster supplement
protease activity was seen at approximately 60 kDa in the
homogenate-supplemented cultures and media controls, especially at the highest dosage levels. This protease activity was
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FIG. 2. Infectivity level and secreted protease profiles of P. marinus
isolate P-1 in plasma and homogenate-supplemented cultures.
(A) Mean body burden ⫾ standard error of oysters infected with P.
marinus isolate P-1 grown for 4 weeks in ODRP-3 medium without
supplementation or supplemented with 0.3 mg of oyster plasma or
homogenate/ml at 27°C in 5% CO2 and then injected at 106 cells per
oyster per day on days 1, 3, and 5 into 30 C. virginica ME oysters per
group. After 4 weeks, the oysters were sacrificed and the total P.
marinus body burden was assessed and loge transformed for statistical
analysis. Groups with different numbers were significantly different (P
⬍ 0.001). (B) Gelatin zymogram of 20 l of culture supernatant from
supplemented and unsupplemented P. marinus cultures from the
above infection trial. Nonreducing, 8% acrylamide, 0.1% porcine gelatin SDS-PAGE gels were incubated for 3 h at 37°C in 0.1 M Tris HCl,
pH 8.0, and then stained with Coomassie brilliant blue G-250. Molecular masses are in kilodaltons.
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FIG. 3. Mean counts of single trophozoites, multicell clusters, and calculated total cell number (see text) from P. marinus isolate P-1 cultures
supplemented with a range of doses of tissue homogenate from five C. virginica WA (CvWA), C. ariakensis (Ca), or C. gigas (Cg) oysters, or with
FBS or fetuin. Cultures were incubated for 6 weeks at 27°C in 5% CO2, resuspended by repeated pipetting, and enumerated with a hemacytometer.
Counts are the mean of duplicate cultures from each of five separate oysters tested. FBS and fetuin were tested in duplicate. Standard error bars,
analysis of variance significance, and multiple comparison results are shown for single trophozoites. Groups with different numbers were
significantly different. Note: homogenates from two of five C. gigas oysters were not in sufficient concentration to allow 1.0-mg/ml supplementation;
therefore, this dose was omitted for these oysters.
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fully inhibited by the addition of 10 mM EDTA to the incubation buffer and is therefore assumed to represent oyster
metalloprotease activity similar to that described by Ziegler et
al. (42).
Oyster tissue homogenates from different oyster species and
populations cause increased infectivity. P. marinus isolate P-1
cell cultures were supplemented with 0.25 mg of oyster homogenate/ml from C. virginica LA, C. virginica WA, C. virginica
TG, C. virginica XB, C. ariakensis, and C. gigas oysters. Cells
from C. ariakensis-, C. virginica LA-, and C. virginica TGsupplemented cultures had a similar mean size of 7.6 to 7.7
m. Cells supplemented with C. virginica XB were slightly
larger, with a mean size of 9.0 m, and those supplemented
with C. virginica WA were smaller, at 5.2 m. Unsupplemented
cultures had a mean cell size of 4.1 m. All homogenatesupplemented cultures formed large clusters of cells resistant
to disaggregation by pipetting. No clusters were noted in the
unsupplemented culture.
All homogenate supplements tested in the infection study
resulted in increased body burdens; however, only those oysters infected with cells pulsed with C. ariakensis or C. virginica
LA homogenate had body burdens significantly different than

that of the ODRP-3 control (Fig. 7A). There was one mortality
in the C. virginica LA group, two in the C. virginica XB group,
and three each in the C. ariakensis and C. virginica WA groups.
Sham-injected oysters were negative for P. marinus infection
and experienced no mortalities. Cells grown in the C. gigas
homogenate-supplemented cultures were not viable at the time
of infection, as assessed by neutral red uptake. The cause of
this is not known, as concentrations of C. gigas homogenate
both above and below this level were used in other experiments
without loss of culture viability. Gelatin zymograms demonstrated induction of low-molecular-weight protease in the C.
virginica LA culture only (Fig. 7B). The unsupplemented
ODRP-3 culture displayed the typical high-molecular-weight
proteases. High-molecular-weight protease activity in the C.
ariakensis and the C. virginica XB cultures was greatly diminished. No protease activity was detected in the media controls.
DISCUSSION
Neither the physical nor the biochemical mechanisms of P.
marinus infectivity or virulence are understood; however, this
parasite can be rapidly attenuated by in vitro culture (16). The
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FIG. 4. Light micrograph (neutral red stain; magnification, ⫻1,000) of P. marinus isolate P-1 cultures supplemented with a range of tissue
homogenate concentrations from five C. virginica WA (CvWA), C. ariakensis (Ca), or C. gigas (Cg) oysters or with FBS or fetuin. Cultures were
incubated for 6 weeks at 27°C in 5% CO2, resuspended by repeated pipetting, and digitally photographed.
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mechanism of this attenuation is not known, but it may be due
to the lack of critical growth, differentiation, or virulence induction factors provided by the host. Previous attempts to
restore virulence by passage of in vitro-cultured parasites
through a host oyster did not succeed, presumably because of
the brief reculture required to produce an inoculum prior to
challenge (16). This suggests that attenuation occurs quite
rapidly.
P. marinus isolates. Nonclonal P. marinus isolates have been
shown to vary in virulence, with Atlantic coast isolates being
more virulent than those from the Gulf of Mexico (4, 5). In this

study, isolates of P. marinus that were chosen based on their
assignment by genetic markers into distinct genotypes (37)
displayed differences in infectivity, as evidenced by the 4-week
body burden (Fig. 1A). The South Carolina isolate, SC3-2, was
associated with the lowest level of infection. Eight of the experimental oysters infected with SC3-2 were negative for P.
marinus infection at week 4, and the highest body burden in
any oyster infected with SC3-2 was 96 cells.
It is possible that the small size of the SC3-2 isolate (⬃2 m)
rendered the cells less likely to be phagocytosed by mantle
cavity hemocytes or ingested during feeding. The efficiency of
particle filtration by oysters varies directly with the size of the
particle (22, 34, 39), and previous studies have demonstrated
that ingestion of P. marinus is one probable route of parasitic
infection (1). While it has also been suggested that hemocytes
in the mantle cavity may be responsible for transport of P.
marinus into the oyster (9, 36), it is not known whether there
are size-mediated differences in rates of phagocytosis and
transport of P. marinus into the oyster by hemocytes. Given
these results, there is an indication that P. marinus cell size
could be a factor in its infectivity.
Supplementation and infectivity. The possibility that cell
size is a determinant of infectivity was not supported, however,
by the results of the other infection trials. When P. marinus P-1
isolate cells were grown in the presence of oyster plasma supplement, the cell size and morphology were similar to those of
unsupplemented cultures. The body burden after experimental
infection, however, was significantly higher and was statistically
similar to that seen with cells enlarged by culture in homogenate-supplemented media. Additionally, despite inducing similar body burdens (Fig. 7A), P-1 cells from cultures supplemented with C. virginica WA and C. virginica XB homogenates
had markedly different mean sizes (5.2 and 9.0 m, respectively). The cells with the greatest infectivity were those supplemented with C. ariakensis homogenate, and they were very
similar in size (mean, ⬃7.6 m) to two other groups with lesser
infectivities, C. virginica LA and C. virginica TG. In this latter
infection study, infections were initiated in C. virginica WA
oysters, and it should be noted that the magnitude of the body
burdens at 4 weeks was markedly lower than was seen in the
earlier trials using C. virginica ME oysters. The cause of this is
not known, but it is assumed that the C. virginica WA oysters
may be more resistant to P. marinus infection. This is particularly interesting because this population of oysters has been
isolated from P. marinus for numerous generations (31).
The ability to increase parasite infectivity appears to be a
property specific to host plasma and tissue homogenates. Supplementation of cell cultures with FBS in Dungan’s medium
does not cause the increases in infectivity seen with oyster
homogenate or plasma supplementation. The mean 4-week
body burden from C. virginica ME oysters infected with P-1
grown in Dungan’s medium with FBS was 2,327 cells (Fig. 1A),
while C. virginica ME oysters infected with P-1 grown in
plasma and homogenate had mean burdens of 18,975 and
25,311, respectively (Fig. 2A).
Morphology, size, and proliferation. Oyster homogenate
supplements were the most effective inducers of morphological
changes, altered the protease profiles, and increased infectivity. Supplementation of medium with homogenates from either
susceptible or tolerant oyster species resulted in a marked
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FIG. 5. Supplemented culture cell size and deviation of pellet volume from unsupplemented control cultures. (A) Cell size ⫾ standard
deviation from P. marinus isolate P-1 cultures supplemented with a
range of tissue homogenate concentrations from five C. virginica WA
(CvWA), C. ariakensis (Ca), or C. gigas (Cg) oysters or with FBS or
fetuin. Cultures were incubated for 6 weeks at 27°C in 5% CO2,
resuspended by repeated pipetting, and measured at 400⫻ magnification using an ocular micrometer. Sizes of 10 trophozoites were measured in duplicated culture wells supplemented with homogenates of
five separate oysters per group. C. gigas (Cg) measurements included
only three oyster supplements at the 1.0-mg/ml dose. (B) Deviation of
calculated pellet volume (see text) of P. marinus isolate P-1 grown in
supplemented cultures from the mean unsupplemented pellet volume.
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reduction in cell proliferation at increasing doses (Fig. 3). At
the 1.0-mg/ml supplementation level for both C. ariakensis and
C. gigas homogenates, there was a decrease in cell number
below the seeding concentration, with the C. ariakensis cells
appearing to be nonviable (Fig. 4). At high supplementation
levels, the diminution was similar between all oyster species
supplements. At the lowest two supplement doses, the suppressive effect was more pronounced in the disease-tolerant C.
ariakensis and C. gigas oysters (Fig. 3). The suppression of
proliferation was only associated with oyster product supplementation. Fetuin supplementation caused a minor decrease in

cell proliferation that was consistent at lower supplement
doses. Both the 0.33- and 1.0-mg/ml supplementation levels
were similar to the ODRP-3 control. FBS behaved similarly,
except that there was a large increase in proliferation at the
0.33-mg/ml, and especially at the 1.0-mg/ml, supplementation
levels. This is in general agreement with the findings of Gauthier and Vasta (19), who previously described the proliferative effects of FBS and fetuin on P. marinus cultures.
Since increasing supplementation levels with oyster homogenates are associated with decreasing cell counts (Fig. 3) and
increasing cell size (Fig. 4 and 5A), it was desirable to under-
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FIG. 6. Gelatin zymogram of 20 l of culture supernatant from P. marinus isolate P-1 cultures supplemented with 1.0 (a), 0.33 (b), 0.11 (c),
0.037 (d), 0.012 (e), or 0.004 (f) mg of tissue homogenate/ml from C. virginica WA (CvWA), C. ariakensis (Ca), or C. gigas (Cg) oysters or with
FBS or fetuin. ODRP-3 is the unsupplemented control. Cultures were grown for 6 weeks at 27°C in 5% CO2. Nonreducing, 8% acrylamide, 0.1%
porcine gelatin SDS-PAGE gels were incubated for 3 h at 37°C in 0.1 M Tris HCl, pH 8.0, and then stained with Coomassie brilliant blue G-250.
Molecular masses are in kilodaltons.
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stand their combined effects using the calculated pellet volumes. The results were not surprising for the FBS and fetuin
cultures. Cell sizes did not change over the range of supplementation and there were no cell clusters, and thus, the pellet
volumes paralleled the cell counts. However, supplementation
with any oyster homogenate was associated with a reduced
pellet volume at the three lowest dosage levels (Fig. 5B). At
0.11 mg/ml, the C. virginica WA-supplemented cells had a
pellet volume in excess of that of the ODRP-3 control. At 0.33
mg/ml, this effect was even more pronounced in the C. virginica
WA oyster group and was seen in both the C. gigas- and C.
ariakensis-supplemented cultures, despite the continuing decrease in cell count. At 1.0 mg/ml, the C. virginica WA culture
pellet volume was nearly 8 mm3 larger than that of the
ODRP-3 control. At this highest supplementation level, the C.
gigas pellet volume again fell below that of the ODRP-3 control, as did that of the nonviable C. ariakensis culture.
In vivo, P. marinus cells range in size from 3.9 to 11.6 m,
with a mean of 5.5 m (35), similar to that elicited by medium
supplementation with oyster products. The association of
larger cell size with lower replication rate may indicate there is
a regulation of mitosis by exposure to host products. P. marinus
appears to regulate its replication, especially at high infection
intensities, such that the parasite burden remains at nonlethal
levels (40). This regulation may be based on energy limitations
(10). The decreased in vivo replication rate could also be
mediated by an ability of P. marinus to sense cell density and
decrease replication rate accordingly, as has been documented
in certain quorum-sensing bacteria (41). This does not seem
likely, as previous studies have found that the presence of P.
marinus cells and extracellular products has a positive effect on
the in vitro replication rate (6, 21). Alternatively, this change
may represent a partial transition to the prezoosporangium life
stage. In fluid thioglycolate medium, trophozoite maturation to
prezoosporangia (hypnospores) is associated with thickening
of the cell wall and marked enlargement of the vacuole, resulting in cell enlargement to 30 to 80 m (35). While this enlargement is considerably greater than is seen in supplemented
cultures, it is nonetheless possible that supplementation results
in the preliminary phases of transition to this life stage.
The present data suggest that there may be a molecular
signal present in all three oyster species tested which regulates
P. marinus proliferation. Since this effect occurs only with tissue homogenates, the signaling molecule could be a product of
tissue degradation. In that case, an increase in the number of
P. marinus cells during infection and the associated tissue damage from proteolytic activity could signal P. marinus to decrease the replication rate and allow the oyster to survive
longer in the parasitized state. This possibility is supported by
the greater potency of the homogenate effect of the tolerant C.
gigas and C. ariakensis oysters on P. marinus cell replication
(Fig. 3).
Protease induction. The initial work investigating the induction of proteases by oyster homogenate (29) was largely confirmed by the dose-response experiment, though there was
some induction of low-molecular-weight proteases by C. ariakensis homogenate, FBS, and fetuin at doses above those assessed in the earlier research. The induction of low-molecularweight proteases did correlate with infectivity in cultures
supplemented with oyster plasma and homogenate (Fig. 3 and
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FIG. 7. Infectivity level and secreted protease profiles of P. marinus
isolate P-1 grown in homogenate supplemented cultures. (A) Mean
body burden ⫾ standard error of oysters infected with P. marinus
isolate P-1 grown for 4 weeks at 27°C in 5% CO2 in ODRP-3 medium
without supplementation or supplemented with 0.25 mg of homogenate/ml from C. ariakensis (Ca) or from C. virginica oysters from
Louisiana (CvLA), Tangier Sound, Chesapeake Bay (Va.; CvTG),
Washington state (CvWA), or from the CROSBreed program (CvXB).
A total of 106 cells per oyster per day were injected on days 1, 3, and
5 into 30 C. virginica WA oysters per group. After 4 weeks, the oysters
were sacrificed and total P. marinus body burden was assessed and loge
transformed for statistical analysis. Groups with different numbers
were considered significantly different (P ⫽ 0.007). (B) Gelatin zymogram of 20 l of culture supernatant from P. marinus isolate P-1 grown
for 4 weeks at 27°C in 5% CO2 in ODRP-3 medium without supplementation or supplemented with 0.25 mg of homogenate/ml as described above. Nonreducing, 8% acrylamide, 0.1% porcine gelatin
SDS-PAGE gels were incubated overnight at 37°C in 0.1 M Tris HCl,
pH 8.0, with 10 mM EDTA included to limit oyster metalloprotease
activity on the zymogram that obscured some of the lower-intensity P.
marinus serine proteases. The gels were stained with Coomassie brilliant blue G-250. Molecular masses are in kilodaltons.
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4). It is tempting to correlate increased infectivity with induction of these proteases under exposure to conditions that more
closely mimic the in vivo environment. The strongest induction
of low-molecular-weight proteases and the highest body burdens were seen in the cells supplemented with homogenate.
Similarly, the intermediate level of protease production by
plasma-supplemented cells was associated with a slightly,
though not significantly, lower body burden. Both were more
virulent than the ODRP-3 control, which produced little to no
low-molecular-weight protease.
The relationship between induction of low-molecular-weight
proteases and increased infectivity was not consistent in the
other experiments. In the clonal isolates grown in Dungan’s
medium, the SC3-2 isolate was the least virulent and demonstrated little to no protease activity in the culture supernatant
(Fig. 1 and 2). The LA10-1 and P-1 isolate also had lower levels
of protease expression in general, and weak low-molecularweight protease expression in particular, and were more virulent than SC3-2. The HVA-18 isolate had infectivity similar to
LA10-1 and P-1, but it had the greatest amount of low-molecular-weight protease expression. The most virulent isolate,
MA2-11, had a level of low-molecular-weight protease expression that was intermediate between that of HVA-18 and
LA10-1 and P-1. It is interesting that the two Virginia isolates,
HVA-18 and P-1, more strongly expressed the series of highmolecular-weight proteases.
When the P-1 isolate was exposed to 0.25 mg of various
oyster homogenates/ml, the C. virginica LA- and C. ariakensissupplemented cultures were the most infective (Fig. 7A).
While the C. virginica LA supplementation induced low-molecular-weight proteases, that supplemented with C. ariakensis
did not. In addition, the C. ariakensis-supplemented medium
elicited a decreased level of high-molecular-weight protease
activity (Fig. 7B). Given these varied results, there does not
appear to be a consistent correlation between the in vitro
induction of low-molecular-weight proteases by homogenate
supplementation and infectivity as measured by week 4 body
burden.
The origin of the low-molecular-weight proteases and their
relationship to the higher-weight forms is not clear. There
often appears to be a diminishment in high-molecular-weight
protease activity associated with increases in the appearance of
the low-molecular-weight forms. It is not known if these
changes in the protease profile are due to changes at the
transcriptional, translational, posttranslational, or secretory
level. Previous research has demonstrated that the low-molecular-weight forms cannot be created from the high-molecularweight forms by incubation in the presence of host products
(29), indicating that the low-molecular-weight forms are likely
not originated by proteolytic cleavage of a multimeric form.
The supplementation of P. marinus cultures with oyster
products from either disease-tolerant or -susceptible oysters
modulates cell proliferation, size, and morphology, as well as
protease expression and infectivity. Many of these effects cannot be reproduced using common bovine media supplements.
None of these varied effects appeared to be linked in all cases,
indicating that exposure to oyster products likely causes a complex alteration in P. marinus physiology, resulting in a multitude of phenotypic and functional changes.
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